Tapewire

Nasdaq · USD

AMRN

AMARIN CORP PLC\UK

Export transactions ↓
Tapewire entity
5970
SEC CIK
0000897448
Parsed reports
411

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 1,528 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 15

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F16 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 220,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F13 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 1,528 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 14

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F16 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 220,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F13 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Tax withholdingOrdinary Shares 19,971 $7.50 $149,782.50
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 13

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,874

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F15 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 12,733 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 12

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F14 · kind: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.

F13 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 26,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 11

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F12 · kind: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.

F13 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,806 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 10

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,636

Underlying: Ordinary Shares · 1,806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,806 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 9

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,636

Underlying: Ordinary Shares · 1,806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 12,733 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 8

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,733

Underlying: Ordinary Shares · 12,733 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F4 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 26,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 7

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 26,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F2 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Tax withholdingOrdinary Shares 1,360 $7.50 $10,200.00
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 6

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,033

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

F7 · balance_after: Please see the section titled "Remarks" below for additional information.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionOrdinary Shares 1,806 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 5

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionOrdinary Shares 1,806 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 4

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Tax withholdingOrdinary Shares 15,351 $7.50 $115,132.50
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 3

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,781

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionOrdinary Shares 12,733 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 2

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · kind: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:02 UTC
Kennedy Joseph TGeneral Counsel
Exercise / conversionOrdinary Shares 26,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 1

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 6,736 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 10

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,152

Underlying: Ordinary Shares · 6,736 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 6,736 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 9

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,152

Underlying: Ordinary Shares · 6,736 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 72,033 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 8

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,033

Underlying: Ordinary Shares · 72,033 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F4 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 216,100 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 123,666 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 7

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 123,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F2 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 371,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Tax withholdingOrdinary Shares 5,302 $7.50 $39,765.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 6

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,881,749

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

F7 · balance_after: Please see the section titled "Remarks" below for additional information.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionOrdinary Shares 6,736 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 5

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,887,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionOrdinary Shares 6,736 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 4

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,880,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Tax withholdingOrdinary Shares 77,460 $7.50 $580,950.00
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 3

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,873,579

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionOrdinary Shares 72,033 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 2

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,951,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · kind: On February 1, 2019, the Reporting Person was granted 216,100 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.

F3 · price: Not applicable.

Read SEC document
January 29, 2021 Filed Jan 30, 2021 01:01 UTC
THERO JOHN FDirector · President and CEO
Exercise / conversionOrdinary Shares 123,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 1

THERO JOHN F · CIK 0001199637 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,879,006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: On February 1, 2018, the Reporting Person was granted 371,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.

F3 · price: Not applicable.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 85,313 $0.00 Strike: $3.80 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 24

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,687

Underlying: Ordinary Shares · 85,313 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 47,605 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 23

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,082

Underlying: Ordinary Shares · 47,605 shares

Expires 2027-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 23,436 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 22

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 23,436 shares

Expires 2026-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 29, 2016. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 29,427 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 21

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,573

Underlying: Ordinary Shares · 29,427 shares

Expires 2025-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 52,938 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 20

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 52,938 shares

Expires 2025-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,797 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 19

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,703

Underlying: Ordinary Shares · 5,797 shares

Expires 2025-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 8,332 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 18

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 8,332 shares

Expires 2025-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,389 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 17

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 25,389 shares

Expires 2025-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 28, 2015. This option was fully vested as of the date hereof.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
SaleOrdinary Shares 143,392 $8.01 $1,149,258.20
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 10

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 388,112

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
SaleOrdinary Shares 278,237 $8.01 $2,228,873.14
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 9

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 531,504

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 85,313 $3.80 $324,189.40
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 8

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 809,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F9 · kind: On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 47,605 $2.95 $140,434.75
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 7

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 724,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F8 · kind: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 23,436 $1.40 $32,810.40
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 6

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F7 · kind: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 29, 2016. This option was fully vested as of the date hereof.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 29,427 $2.50 $73,567.50
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 5

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 653,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 52,938 $2.50 $132,345.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 4

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 623,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 5,797 $2.50 $14,492.50
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 3

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 571,022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 8,332 $2.50 $20,830.00
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 2

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 565,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.

Read SEC document
January 27, 2021 Filed Jan 30, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
Exercise / conversionOrdinary Shares 25,389 $1.02 $25,896.78
Disclosure

SEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 1

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · kind: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 28, 2015. This option was fully vested as of the date hereof.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:05 UTC
Berg AaronCHIEF COMMERCIAL OFFICER
GrantRestricted Stock Units · Derivative 143,300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000129 · primarydocument.xml · derivative · entry 7

Berg Aaron · CIK 0001770259 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,300

Underlying: Ordinary Shares · 143,300 shares

Expires not disclosed

F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:05 UTC
Berg AaronCHIEF COMMERCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 193,500 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001562180-21-000129 · primarydocument.xml · derivative · entry 6

Berg Aaron · CIK 0001770259 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,500

Underlying: Ordinary Shares · 193,500 shares

Expires 2031-01-04

F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:04 UTC GrantRestricted Stock Units · Derivative 143,300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000128 · primarydocument.xml · derivative · entry 7

Kalb Michael Wayne · CIK 0001678248 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,300

Underlying: Ordinary Shares · 143,300 shares

Expires not disclosed

F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:04 UTC GrantStock Option (Right to Buy) · Derivative 193,500 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001562180-21-000128 · primarydocument.xml · derivative · entry 6

Kalb Michael Wayne · CIK 0001678248 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,500

Underlying: Ordinary Shares · 193,500 shares

Expires 2031-01-04

F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
GrantRestricted Stock Units · Derivative 143,300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000127 · primarydocument.xml · derivative · entry 7

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,300

Underlying: Ordinary Shares · 143,300 shares

Expires not disclosed

F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:03 UTC
Ketchum Steven BChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 193,500 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001562180-21-000127 · primarydocument.xml · derivative · entry 6

Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,500

Underlying: Ordinary Shares · 193,500 shares

Expires 2031-01-04

F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 01:03 UTC
Kennedy Joseph TGeneral Counsel
GrantRestricted Stock Units · Derivative 143,300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000126 · primarydocument.xml · derivative · entry 7

Kennedy Joseph T · CIK 0001408920 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,300

Underlying: Ordinary Shares · 143,300 shares

Expires not disclosed

F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023.

F3 · derivative.expiration_date: Not applicable.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.